Role of p53 in HER2-induced proliferation or apoptosis

被引:40
作者
Casalini, P [1 ]
Botta, L [1 ]
Ménard, S [1 ]
机构
[1] Ist Nazl Tumori, Dept Expt Oncol, Mol Targeting Unit, I-20133 Milan, Italy
关键词
D O I
10.1074/jbc.M009732200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HER2 oncogene overexpression has been associated either with proliferation or differentiation and apoptosis. The role of p53 on these different chances was investigated. Wild type (wt) p53-IGROV1 cells showed growth inhibition and apoptosis after HER2 transfection, whereas no anti-proliferative effect was observed in its mutated p53 sub-line unless wt p53 was cotransfected with HER2. Stable HER2 transfectants derived from wt p53 line treated with heregulin-beta1 or epidermal growth factor showed a decrease in proliferation due to a G(2)/M cell cycle block. despite normal mitogen activated protein kinase activation. In these HER2 transfectants, c-Myc and p53 expression were increased, whereas MDM2 was dramatically down-modulated. Ey contrast, growth factors stimulation of HER2 transfectants with mutated-p53 induced progression through the cell cycle. Together, our data point to a regulatory role for p53 in HERS signaling.
引用
收藏
页码:12449 / 12453
页数:5
相关论文
共 34 条
  • [1] Regulation of p53 stability
    Ashcroft, M
    Vousden, KH
    [J]. ONCOGENE, 1999, 18 (53) : 7637 - 7643
  • [2] Bacus SS, 1996, ONCOGENE, V12, P2535
  • [3] BACUS SS, 1994, AM J CLIN PATHOL S1, V102, P13
  • [4] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [5] Enhanced phosphorylation of p53 by ATN in response to DNA damage
    Banin, S
    Moyal, L
    Shieh, SY
    Taya, Y
    Anderson, CW
    Chessa, L
    Smorodinsky, NI
    Prives, C
    Reiss, Y
    Shiloh, Y
    Ziv, Y
    [J]. SCIENCE, 1998, 281 (5383) : 1674 - 1677
  • [6] Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities
    Beerli, RR
    Hynes, NE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) : 6071 - 6076
  • [7] CASCINELLI N, 1991, CANCER-AM CANCER SOC, V68, P427, DOI 10.1002/1097-0142(19910715)68:2<427::AID-CNCR2820680236>3.0.CO
  • [8] 2-Y
  • [9] P185 HER2/NEU EPITOPE MAPPING WITH MURINE MONOCLONAL-ANTIBODIES
    CENTIS, F
    TAGLIABUE, E
    UPPUGUNDURI, S
    PELLEGRINI, R
    MARTIGNONE, S
    MASTROIANNI, A
    MENARD, S
    COLNAGHI, MI
    [J]. HYBRIDOMA, 1992, 11 (03): : 267 - 276
  • [10] Daly JM, 1997, CANCER RES, V57, P3804